Insulin resistance: a metabolic pathway to chronic liver disease.
about
Hepatic steatosis: a benign disease or a silent killerMetabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential linkHepatitis C virus and type 2 diabetesMechanisms of Diabetes-Induced Liver Damage: The role of oxidative stress and inflammationNon-Alcoholic Fatty Liver Disease and Extra-Hepatic CancersAnimal Models of Nonalcoholic Steatohepatitis: Eat, Delete, and InflameComorbidities and Metabolic Derangement of NAFLDHepatitis C virus infection and type 1 and type 2 diabetes mellitusObesity and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese populationMetabolic factors and chronic hepatitis C: a complex interplayHepatic circadian-clock system altered by insulin resistance, diabetes and insulin sensitizer in miceMolecular mechanisms of insulin resistance in chronic hepatitis CMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseSirtuins and nonalcoholic fatty liver diseaseTreatment of nonalcoholic fatty liver disease: role of AMPK.Analyzing the Impact of Increasing Mechanical Index and Energy Deposition on Shear Wave Speed Reconstruction in Human LiverNon-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.Has natural selection in human populations produced two types of metabolic syndrome (with and without fatty liver)?The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general populationA vascular piece in the puzzle of adipose tissue dysfunction: mechanisms and consequences.Prediction of metabolic syndrome by non-alcoholic fatty liver disease in northern urban Han Chinese population: a prospective cohort study.Changes in human hepatic metabolism in steatosis and cirrhosis.Serum oxidative stress markers and lipidomic profile to detect NASH patients responsive to an antioxidant treatment: a pilot study.Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinomaThe Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population.Insulin resistance is associated with hepatocellular carcinoma in chronic hepatitis C infection.Insulin resistance, adipokine profile and hepatic expression of SOCS-3 gene in chronic hepatitis C.Synergy analysis reveals association between insulin signaling and desmoplakin expression in palmitate treated HepG2 cellsAMPK-Dependent Metabolic Regulation by PPAR Agonists.On-site Basic Health Screening and Brief Health Counseling of Chronic Medical Conditions for Veterans in Methadone Maintenance TreatmentNon-alcoholic steatohepatitis and influence of age and gender on histopathologic findingsOsthol attenuates hepatic steatosis via decreased triglyceride synthesis not by insulin resistanceUpper limits of normal for serum alanine aminotransferase levels in Chinese Han population.Insulin receptor Thr1160 phosphorylation mediates lipid-induced hepatic insulin resistance.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C > G) in the development of fatty liverMicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.Adipokines and proinflammatory cytokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease.Physical Activity is Related to Fatty Liver Marker in Obese Youth, Independently of Central Obesity or Cardiorespiratory Fitness.Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease.
P2860
Q22305506-A8D27EA9-244D-4F60-B222-12E8C839D0D7Q24631619-75198869-5B8B-4932-9E8E-3392CB98B38BQ24658049-FB4AC063-6E8E-4A40-9A67-059CE21F6B2DQ26745839-EB393A9C-2C1A-4978-BBF6-069B0251010DQ26749045-D261B183-FB72-4154-8DA3-0F04D3415942Q26775571-02477955-BB7D-4883-9CA1-8C307024E10CQ26777147-91865763-8031-485A-8056-E3F1058A61CBQ26829202-61A50C03-B0D9-414B-833F-E9083D0659C2Q27003363-DC90D4FA-8800-4A72-8E92-A45AC53CC8CFQ27011787-317D7E74-EF54-4C48-954D-B21F6803C1BDQ27311473-3190CF55-0912-4C47-AE0F-E2C6D60A6A6CQ27489665-0321AED3-77DC-4630-A9D1-B46D4A62D199Q28067490-9FB49EAA-572E-40C5-ACB7-248D5DDA561AQ28079953-20B78791-BC2B-4E81-B0EA-F3EF1812ECE9Q30248230-193C81C9-D9ED-4F68-A574-518353FB9161Q30380564-E0BEB50F-25F2-4062-A053-64C8E5053171Q30389752-5A406A6C-9D0C-4129-AFD9-DE5F1B7546F2Q30443852-E1F824C0-A1A2-4A56-A1D3-74B4B26AFA0DQ33262505-E09D303B-7BF2-4355-9531-D0CBB4B938C2Q33356605-C88D0103-FD31-4043-8A8B-3507254CF44EQ33573424-789D987D-90AE-4A3C-8CBC-A218A287CDCEQ33599515-60622782-5269-4863-B804-F3E6B6551241Q33765372-597E62B6-BFDD-432D-AC48-0D2DA00F3322Q33798871-A78B58CC-B091-4FDB-A623-96ED043B52A0Q33798979-D14EC09A-91E8-43CE-A875-DB5854512680Q33844192-E12B28B2-45DE-46D6-A81B-774AA2D6F37CQ34036689-E6EC739C-6381-43FF-8C0A-BD0F9C27953FQ34088181-F3E8EEBD-A9A1-4DD9-968E-642FC9F4D9FAQ34089730-AB440060-22F0-4782-BC4F-995CCF3B36F4Q34093399-24998E94-BC3B-49B4-828D-2F4A0314091BQ34102001-996EF2E9-523F-4FB3-B9D5-E36231E99453Q34137340-48A00453-BA5C-4D3A-8A5B-58BB50514B22Q34409744-ECC01E8C-8AD1-4B60-8B6A-A059C1BCA2EAQ34543004-7A3BC1E0-11CB-4BCC-B690-5AB52A48D989Q34571695-2A28BEEE-CC4A-46DB-BB9D-455A24F35BE3Q34728811-AE4BA70B-48CB-40DB-8713-2C9703E30F7DQ34750679-35ED8616-164F-4A99-91E4-36F7D2B1B6B1Q34779049-732C83E9-13A4-450E-9A33-69B897D467CFQ35014575-9DA855A1-4037-4B1B-A254-C092E9A956E0Q35022435-A72AD535-5BDF-4E09-ABCC-7494869B5C2D
P2860
Insulin resistance: a metabolic pathway to chronic liver disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Insulin resistance: a metabolic pathway to chronic liver disease.
@ast
Insulin resistance: a metabolic pathway to chronic liver disease.
@en
type
label
Insulin resistance: a metabolic pathway to chronic liver disease.
@ast
Insulin resistance: a metabolic pathway to chronic liver disease.
@en
prefLabel
Insulin resistance: a metabolic pathway to chronic liver disease.
@ast
Insulin resistance: a metabolic pathway to chronic liver disease.
@en
P356
P1433
P1476
Insulin resistance: a metabolic pathway to chronic liver disease.
@en
P2093
Arthur J McCullough
Giulio Marchesini
P304
P356
10.1002/HEP.20920
P407
P577
2005-11-01T00:00:00Z